ISSN   0974-3618  (Print)                  www.rjptonline.org

            0974-360X (Online)

 

 

RESEARCH ARTICLE

 

Evaluation of Anti Depressant and MAO Inhibitory Activity of Rhodiola rhodantha rhizome methanolic extract

 

Anantha Lakshmi J*, Satyavthi D.

1Sri Venkateshwara College of Pharmacy, Madhapur, Hyderabad, Telangana State

2Sree Datta Institute of Pharmacy, Sheriguda, Ibrahimpatnam, Ranga Reddy Dist.

*Corresponding Author E-mail: anu_manas0108@yahoo.com

 

ABSTRACT:

The objective of the present study was to evaluate the antidepressant activity of methanolic extract for the rhizomes of Rhodiola rhodantha. Depression  is  the most  common  feature  and  it  may  range  from  a very mild  condition  to  even  severe depression  which  is  called  as  psychotic depression. In the traditional systems of medicine many plants and formulations have been used to treat depression for thousands of years. The present study was undertaken to assess the antidepressant effect of crude methanolic extract of Rhodiola rhodantha at doses 100mg/kg, 200mg/kg and 400mg/kg using  parameters  forced induced swimming test (FST), tail suspension test (TST). Significant dose dependent decline in immobility time was observed in all the three doses in FST and TST and the extract showed dose-dependent relation of immobility reduction in mice. In order to understand the probable mechanism of antidepressant-like activity in FST and TST, the levels of 5-hydroxy indole acetic acid in urine was taken as basis for biochemical assessment of anti depressant activity.

The antidepressant activity of extract was comparable to that of standard drug imipramine. The results of the present study indicate the potential for use of RRMS as an adjuvant in the treatment of depression.   

 

KEYWORDS: Forced swim test, Tail suspension test, Depression, Rhodiola rhodantha, imipramine

 

 


INTRODUCTION:

Depressive disorder is a prevalent psychiatric disorder, which affects 21% of the world population. Mental depression is one of the common chronic illnesses that affect the mood, thought, physical health and behavior of an individual often associated with suicidal tendency. In spite of the availability of various classes of drugs, psychological disorders continue to be a major medical problem. The drugs used to treat this disorder has a success rate of about 60% and  in addition, most therapies require several weeks of treatment  and produces  severe toxic and  side effects (1,2).

 

People from different regions of the world have used herbal medicines to alleviate affective disorders for many years. In addition, the search for novel pharmacotherapy from medicinal plants for psychiatric illnesses has progressed significantly in the past decade.

 

 

 

Received on 31.12.2014          Modified on 03.01.2015

Accepted on 20.01.2015         © RJPT All right reserved

Research J. Pharm. and Tech. 8(3): Mar., 2015; Page 310-315

DOI: 10.5958/0974-360X.2015.00051.7

 

An increasing number of herbal products have been introduced into psychiatric practice, among the most commonly used herbal medications for the prevention or treatment of depression. Various plants are being used in complementary and alternative medicines for management of stress and mood disorders, because of their minimum toxicity (3-5).

 

Rhodiola rhodantha (A. Gray) H. Jacobsen is a dicot plant belongs to the Crassulaceae family. It is known locally as red pod stonecrop. The plant is a perennial herb growing to 0.4 m (1ft4in). All members of this genus are reported to have edible properties. However no regular cultivation is practiced. It flowers from July to August and the seeds ripen from Aug to September(6,7). Rhodiola species reported to strengthen the nervous system, fight depression, enhance immunity, elevate the capacity for exercise, enhance memory, aid weight reduction, increase sexual function and improve energy levels (8).

 

 

 

EXPERIMENTAL:

Selection, collection and authentification of plant

The authenticated Rhodiola rhodantha were kindly provided by Dr. Madhavan Chetty, Botanist, Tirupathi Andhra Pradesh, India. All the plant materials were further identified and authentified by Dr. Madhavan Chetty, Department of Botany, Sri Venkateswara University, Tirupathi, Andhra Pradesh. The specimens have been preserved in air tight containers.

 

Preparation of Extract

A wide range of solvents with increasing polarity were chosen and maceration technique was employed for extraction process. In a 250ml round bottomed flask, weighed quantity of powdered drug were macerated with the respective solvent methanol (i.e. 50gm in 100ml) and kept with occasional shaking for a period of 72 hrs. After the maceration process, the active ingredients present in the supernatant solvent were collected in petridishes and concentrated under reduced pressure. Specific emphasis was given to determination of phytomedicines. 

 

Preliminary phytochemical screening:

The plant extract was subjected to preliminary phytochemical screening. The extracts of Rhodiola rhizomes were treated with dilute hydrochloric acid and filtered. The filtrate was treated with various alkaloid agents. The presence of alkaloids was evaluated using Mayer’s test, Dragendroff’s test, Hager’s and Wagner’s test. Along with this other tests such as Fehlings, Benedict’s test, Barfoed’s test were conducted to evaluate the presence of reducing and non reducing sugars. The extract was evaluated for the presence of glycosides. The extracts were treated with million’s reagent, biuret’s test to detect the presence of proteins. Additionally all the plant extracts were evaluated for the presence of sterols, steroids, mucilage and terpens.

 

Acute toxicity studies:

Standardization of the therapeutic dose and confirmation of any acute toxicity was assessed by conducting acute toxicity studies using OECD guidelines. The acute toxicity was determined by using female albino mice (20-30g) those maintained under standard husbandry conditions. The animals were fasted 3 hrs prior to the experiment, up and down procedure (OECD guideline no. 425) of CPCSEA was adopted for toxicity studies. Animals were administered with single dose of formulation and observed for its mortality during 48 hours study period (short term) toxicity. Based on short term profile of drug, the dose of the next animals was determined as per as OECD guideline 425. The treated animals were carefully observed individually for the toxicity signs and mortality. The animals were observed for mortality for 24 hr after drug administration. The LD50 of the test extract was calculated using AOT 425 software provided by Environmental protection agency, USA.

 

 

 

In acute toxicity studies all the plant extracts were evaluated for parameters such as Alertness, Aggressiveness, Pile Increased Motor Activity, Tremors, Convulsions, Respiration and Number of Deaths (Mortality).

 

Anti depressant activity

The antidepressant effect of selected plant extracts were evaluated using two behavioral models the forced swim test (FST) and tail suspension test (TST). In addition MAO inhibitory studies were conducted for the methanolic extract of rhodiola root.

 

Drug treatment and schedule

The animals were divided into five groups consisting of 6 mice per group. Group I received vehicle (control), group II received  the standard imipramine (20 mg/kg,p.o.) group III, IV, V received methanolic extracts of Rhodiola Rhizomest Methanolic extract, (100mg/kg,p.o), (200mg/Kg, P.O) and (400mg/Kg, P.O)  respectively. Each extracts and the reference compound were injected 30 min before administration of imipramine(9).

 

Forced swim test (FST)

Behavior despair was proposed as a model to test for antidepressant activity by, Mice were forced to swim individually in a glass jar (25 × 12 × 25 cm3sub) containing fresh water of 15 cm height and maintained at  a temperature of 25°C (± 3°C). After an initial 2 min period of vigorous activity, each animal assumed a typical immobile posture. A mouse was considered to be immobile when it remained floating in the water without struggling, making only minimum movements of its limbs necessary to keep its head above water. The total duration of immobility was recorded during the next 4 min of a total 6 min test. The changes in immobility duration were studied after administering drugs in separate groups of animals. A decrease in the duration of immobility is indicative of an antidepressant effect.

 

Tail suspension test (TST)

The total duration of immobility induced by tail suspension was means measurement according to the method described by Steru et al. Mice were suspended on the edge of a table 50 cm above the floor by the adhesive tape placed approximately 1 cm from the tip of the tail. Immobility time was recorded during a 6 min period. Animal was considered to be immobile when it did not show any movement of body and hanged passively. The immobility time was calculated.

 

MAO Inhibitory activity

The animals were randomly divided into five groups each containing six rats. They were marked with unique identifications and they were arranged in metabolic cages suitable for the collection of urine (10).

 

Rats of group A served as control and were treated orally with 2% gum acacia suspension. Rats of groups B were treated respectively with moclobemide 100mg/kg orally suspended in 2% gum acacia. Rats of group C, D, E were administered with methanolic extracts of Rhodiola Root extract at a doses (100mg/kg,p.o), (200mg/Kg,P.O) and (400mg/Kg,P.O) respectively in 2%gum acacia suspension. The treatment was given for 3 days in all groups and  24 hr urine samples were collected daily for 3 days before, during and after for 4 days of  the treatment. The volume of urine collected during 24 hrs was noted and the aliquots of urine sample were analysed for 5-HIAA as described below.

 

Preparation of stock solution of 5-HIAA: A stock solution was prepared by dissolving 50 mg of 5-HIAA in 100 ml of distilled water in a volumetric flask, which represents 0.5mg/ml of solution. From the above stock solution further dilutions were made to represent 50,100,200,400,600 and 800mcg/10ml of the solution.

 

1,1-Nitroso-2-napthol (0.1% solution) in ethanol, Nitrous acid reagent (5ml of 2N sulphuric acid, 0.2ml of 2.5% of sodium nitrate), 2,4-Di nitro phenyl hydrazine in 2N HCl and Phosphate buffer (0.5N) PH>7.0 were used as reagents. Diethyl ether (reagent grade) was washed with dilute solution of ferrous sulphate to remove peroxides.

 

Monamine Oxidase Inhibitory Activity

The biogenic amine 5-HT is oxidized by MAO to 5-hydroxy indole acetic acid (5-HIAA) as a major metabolite which is excreted in urine (Udenfriend et al., 1955). Hence the reduction in the urinary 5-HIAA level from normal after treatment with the test compound was taken as a criteria for it’s MAO inhibitory action (11).

 

In the present work, the MAO inhibitory activity was studied by biochemical method where the urinary excretion of metabolite of 5-HT was determined in urine samples of rats and it was compared with that of moclobemide, a known MAO inhibitor which was used as a reference substance.

 

As per the method reported by Udenfriend et.al the 5-HIAA in solutions and urine samples was determined by measuring the optical density at 540nm on treating it with nitroso napthol reagent followed by nitrous acid reagent, after removal of the interfering keto acids by treating with 2,4dinitrophenyl hydrazine and extracting with chloroform.

 

Method: To prepare 10ml of standard solution in a 50 ml glass stoppered bottle, 10ml of 2,4dinitrophenyl hydrazine reagent was added. After 30min 25ml of chloroform was added, shaken for 10min and then centrifuged. After phase separation organic layer was removed and replaced with 25ml of chloroform and the extraction was repeated. After centrifuging, 15ml of aqueous layer was taken into 50ml stoppered bottle to this 8g of sodium chloride and 25ml of ether were added. These bottles were shaken for 5min on a shaker and centrifuged. After centrifugation and phase separation 20ml ether was taken into 50ml glass stoppered bottle containing 4ml of phosphate buffer at pH 7.0. It was shaken for 5min, centrifuged and ether was removed by aspiration. Later 3ml of buffer layer was taken into 15ml stoppered tubes and to this 1.5 ml of nitroso napthol reagent and 1.5ml of nitrous acid reagent were added and mixed well and were kept at 37°c for 5min. Then 5ml of ethyl acetate were added and after phase separation the ethyl acetate layer was aspirated. The above step was repeated with another 5ml of ethyl acetate and the absorbancy of aqueous solution was measured at 540nm against reagent blank.

 

Statistical analysis:

In this investigation, the results were expressed as mean ± standard deviation (n = 6). The data were analyzed statistically by one way analysis of variance (1ANOVA) compared. while p<0.05was considered statistically significant in all cases. The software package graph pad prism version 6.0 was used for analysis of data.

 

RESULTS AND DISCUSSION:

The phyto chemical constituent evaluation of Rhodiola rodantha rhizomes extract showed the presence of alkaloids, glycosides, flavonides, tannic acid, tannins and pseudo tannins. The presence of alkaloids, glycosides and tannins which was attributed to be responsible for psycho neuro pharmacological activity.


 

Figure-1:Immobility time profile of forced swim test for methanolic extract of Rhodiola rhodanta extract


 

 

In the acute toxicity studies no toxic symptoms or mortality were observed in any animals, which lived up to 14 days after the administration of  methanolic extract at single dose level of 5000 mg/kg body weight. A starting dose of 2000mg/kg body weight /p.o of methanolic extracts were administered to 3 female rats, observed for 14 days. When the experiments were repeated again with the same dose level, no changes were observed from the first set of experiment. The extracts at lower does not changed alteration in Alertness, Aggressiveness, Pile erection, Muscle relaxant and Hypnosis effect and a significant differences were observed at higher doses. The signs of tremors, convulsions, respiratory depression and death were not observed at low and higher doses. The above studies indicate that the extract of rhodiola is safe and the selected doses are below the lethal dose.

 

Forced Swim Test (behavioural despair test):

In this study, we evaluated the antidepressant effects of methanolic extract of R.  rhodantha using forced swimming test and tail suspension test. Both the paradigms are widely accepted behavioral models for assessing antidepressant activity. For this purpose duration of immobility and swimming times of the three doses of methanolic extract from R. rhodantha in comparison with negative control and imipramine (positive control) were studied. In this test when animal forced to swim in a restricted area initially has vigorous activity and then showed an immobile posture and restricted movement which is indicative of lowered mood was presumed to have antidepressant effects.

 

A significant (P<0.01) decrease in the duration of immobility was seen with the standard drug imipramine in all the tested doses. All the extracts in doses of 200mg/kg and 300mg/kg produced a greater decrease in the duration of immobility as compared to the standard drug imipramine. Results indicated that in lower dose of the extract (100 mg/kg) immobility times (Figure-2) did not changed compared to the control group. However, at higher concentrations of extract duration of immobility (200 and 400mg/kg) significantly increased and decreased immobility respectively.

 

Exact mechanisms underlying the antidepressant action cannot be concluded at the moment due to the presence of large number of phyto chemicals. However the antidepressant activity may be attributed to the presence of tannic acid, gallic acid, polyphenols in the extract. Tannic acid has been shown to be a non selective inhibitor of monoamine oxidase, thereby increasing the levels of mono aminergic neurotransmitters in the brain. Another possible mechanism of action is the attenuation of oxidative stress produced during depression, by the polyphenols and tannic acid.

 

TAIL SUSPENSION TEST:

In this test animals were treated with three doses of RRME (100, 200 and 300 mg/kg) showed significant decrease in their immobility times. Similarly, animals treated with imipramine (20 mg/kg) showed a significant decrease in the immobility time. Tail suspension test produced a marked reduction in immobility time at doses of 200 and 400 mg/kg in the rat with a profile comparable to that observed for the classical antidepressant drug imipramine. The plant extracts showed dose proportional relationship with time of immovability. In this test, the immovable time decreased significantly with increase in the dose level of methanolic extract (200mg/kg & 400mg/kg) of rhodiola root.

 


 

Figure-2:Immobility time profile of tail suspension test for methanolic extract of rhodiola rhodanta extract

 

 

 

Table-1:r Rhodiola rodantha rhizome methanolic extract measuring immobility( time in sec ).

S.No

GROUPS

IST DAY

2ND DAY

3RD DAY

4TH DAY

5TH DAY

6TH DAY

7TH DAY

1

Control

120.83±3.29

127±2.12

125.5±3.60

126.0±0.93

128.6±2.17

126.66±2.1

127.6±2.17

2

Imipramine 20MG/KG

60.5±1.99

55.5±1.33

47.33±1.33

48.5±0.76

47±1.39

45.5±2.04

41.33±1.08

3

RRME 100MG/KG

92.83±2.62

80.66±1.11

74.33±1.35

69.5±0.42

66.33±1.08

63.0±2.32

62.33±2.24

4

RRME 200MG/KG

79.33±1.9

72.5±1.08

66.0±1.39

65.16±0.94

61.83±0.60

61.83±0.60

59.83±0.47

5

RRME 400MG/KG

50.83±1.27

50.33±1.11

44.0±1.06

43.0±0.966

42.0±0.73

38.66±1.66

36.5±1.05

 

 

MAO INHIBITORY ACTIVITY:

Figure-3. MAO inhibitory activity rhodiola root  showing 5-HIAA levels in urine

 

Table-2  5-HIAA levels in urine showing MAO inhibitory activity of rhodiola root 

S.

NO

TREATMENT

CONTROL

STANDARD

RRME(100MG/KG)

RRME (200MG/KG)

RRME (400MG/KG)

 

BEFORE TREATMENT

 

 

 

 

 

 

1ST DAY

228.4

370.2

262.1

208.9

256.5

 

2ND DAY

238.6

302.6

264.7

201.6

296.5

 

3RD DAY

241.0

298.2

258.9

196.0

268.4

 

MEAN±S.E.

236±3.86

323.66±23.3

261.9±1.67

202.16±3.7

273.8±11.85

 

DURING TREATMENT

 

 

 

 

 

 

4TH DAY(1)

250.0

290.8

246.0

176.2

126.1

 

5TH DAY(2)

255.0

168.2

208.2

148.5

109.6

 

6TH DAY(3)

242.1

118.0

186.1

119.6

74.1

 

MEAN±S.E

249.03±3.7

195.06±50.66

213.4±17.48

148.1±16.34

129.93±33.39

 

AFTER TRATMENT

 

 

 

 

 

 

7TH DAY(1)

229.1

128.9

192.5

102.5

66.3

 

8TH DAY(2)

252.8

204.5

201.6

128.7

78.5

 

9TH DAY(3)

246.6

268.1

234.5

156.1

102.1

 

10TH DAY(4)

235.0

308.9

240.7

189.0

128.9

 


Average mean values of 3 such determinations for rhodiola extract are given in Table-2. A linear relationship between the amount of 5-HIAA was found in the range of 66 to 273 mcg. A positive correlation between concentration of 5-HIAA and the concentration of rhodiola extract was observed. The amount of 5-HIAA in the unknown sample was directly read from the standard graph. The 5-HIAA levels in urine samples were analysed in the same manner as described earlier and the amount of 5-HIAA excreted during 24hrs was calculated.

 

The percentage changes of 5-HIAA levels calculated from average of the values obtained on the 3 days prior to drug treatment was also shown in the Table-3. The significance of rhodiola extract on urinary 5-HIAA levels compared to pre treatment levels was tested. All the drugs produced significant change. The percentage off change in 5-HIAA levels observed with (500mg/kg) rhodiola was equivalent to that of moclobemide (50mg/kg) indicating that they produced similar effect. Also the percentage change of 5-HIAA levels observed with rhodiola (400mg/kg) was almost equal to that of Moclobemide (100mg/kg) indicating that they produced similar effect.

 

CONCLUSION:

In conclusion Rhodiola rodantha root methanolic extract has shown significant antidepressant activity greater than imipramine and it has the potential to be used as an antidepressant.

 

ACKNOWLEDGMENT:

We are grateful to the management of Sri Venkateswara College of Pharmacy for providing the facilities to carry my research work.

 

REFERENCES:

1.        Borsini F, Meli A, Is the forced swimming test a suitable model for revealing antidepressant activity, Psychopharmacology, 94; 1988: 147-160.

2.        Dhingra D, Sharma A, Antidepressant-like activity of Glycyrrhiza glabra, Neuropsychopharmacol. Biol. Psychiatry. 30; 2006: 449.

3.        Dunham N.M, Miya T.S. A note on simple apparatus for detecting Neurological deficit in rats and mice, J. Am. Pharm, 46; 1957: 208-9.

4.        Guo Y, Kong L, Wang Y, Huang Z, Antidepressant evaluation of polysaccharides from a Chinese herbal medicine Banxia-houpu decoction, Phytother.Res.18; 2004:204-207.

5.        Van Diermen D, Marston A, Bravo J, Reist M, Carrupt PA, Hostettmann K.Monoamine oxidase inhibition by Rhodiola rosea L. roots. J Ethnopharmacol.2009; 122(2):397-401. doi: 10.1016/j.jep.2009.01.007. Epub 2009 Jan 9.

6.        C. B. Nemeroff, “The burden of severe depression: a review of diagnostic challenges and treatment alternatives,” Journal of Psychiatric Research, 41(3-4); 2006: 189–209.

7.        Haque AM, Hashimoto M, Katakura M, Tanabe Y, Hara Y, Shido O. Long-term administration of green tea catechins improves spatial cognition learning ability in rats. J Nutr 2006; 136:1043-7.

8.        Joshi H, Parle M. Brahmi rasayana improves learning and memory in mice. eCAM 2006;3(1):79-85.

9.        Calabrese C, Gregory WL, Leo M, Kraemer D, Bone k, Oken B. Effects of a standardized Bacopa monnieri Extract or cognitive performance, anxiety and depression in elderly: a randomized double blind placebo controlled trial. J Altern complement Med.2008; 14: 707-3.

10.     Tang JL, Zeng YS, Chen QG, Qin YJ, Chen SJ, Zhong ZQ. Effects of valerian on the level of 5- hydroxyl tryptamine, cell proliferation and neurons in cerebral hippocampus o rats with depression induced by chronic mild stress. Zhan Xi Yi Jie He Xue Bao 2008; 6: 283-8.

11.     Hou WC, Lin RD, Chen CT, Lee MH. Monoamine oxidase B (MAO-B) inhibition by active principles from Uncaria rhynchophylla. J Ethnopharmacol 2005; 100(1-2):216-20.